Caffeine Disposition After Inhalation
NCT02184104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2017-10-26
Summary
The purpose of this study is to determine how fast caffeine gets into your body with a product called Aeroshot™. Aeroshot™ is a lipstick sized device that you slide open and then put your mouth over the opening and inhale. A fine powder containing 100 mg of caffeine is deposited on your tongue and the inside of your mouth. Caffeine will be absorbed through the membranes in your mouth or swallowed and then absorbed in your stomach. We will compare the absorption of caffeine after using the Aeroshot™ with the absorption after drinking an energy drink by taking 15 blood samples over 8 hours and measuring the caffeine levels in your blood. You will also be asked to fill out some scales to measure the effects you feel after the caffeine dose. We hypothesize that caffeine absorption after inhalation will be faster than after an energy drink.
Conditions
- Healthy
Interventions
- DIETARY_SUPPLEMENT
-
Caffeine
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
University of Tennessee
lead OTHER
Principal Investigators
-
Steven C. Laizure, Pharm.D. · University of Tennessee
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2015-11-30
- Completion
- 2017-03-20
Countries
- United States
Study Locations
More Related Trials
-
Effect of Caffeine Consumption on Protein Biomarkers and Cardiovascular Disease
NCT06359197 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Clinical Trial on the Effects of Caffeine and Taurine From Energy Drinks (EDs) to Parameters of the Cardiovascular System in Humans
NCT01421979 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Effects of Oral DMAA
NCT01765933 ·Status: COMPLETED ·Phase: NA
-
The Development of Oral Nalbuphine Dosage Form
NCT00924079 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Caffeine on Pain-Based Pacing During a Cycling Time-Trial
NCT02115763 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity
NCT06978777 ·Status: RECRUITING ·Phase: NA
-
Pharmacology Space Kit (PSK) - Dried Blood Spot for Caffeine Pharmacokinetics Under Microgravity Conditions
NCT06431984 ·Status: COMPLETED ·Phase: NA
-
Acute Caffeine Effects on Cardiac Autonomic and Cardiorespiratory Parameters Responses After Aerobic Exercise
NCT02917889 ·Status: UNKNOWN ·Phase: NA
-
Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male Subjects
NCT02259985 ·Status: COMPLETED ·Phase: PHASE1
-
Reproducibility of Acute Caffeine Effect
NCT06606639 ·Status: COMPLETED ·Phase: NA
-
Effects of Caffeine on Methacholine Challenge and Exhaled Nitric Oxide Levels.
NCT01057875 ·Status: COMPLETED ·Phase: NA
-
A Single-Dose Positron Emission Tomography (PET) Study to Determine the Effect of TAK-041 on Amphetamine-Induced Dopamine Release in the Central Nervous System (CNS)
NCT02959892 ·Status: COMPLETED ·Phase: PHASE1
-
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
NCT00826280 ·Status: COMPLETED ·Phase: PHASE3
-
Direct Effect of Caffeine on Diaphragmatic Muscles
NCT04483492 ·Status: UNKNOWN
-
Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?
NCT00205166 ·Status: COMPLETED ·Phase: NA
-
Acute Caffeine Ingestion on Futsal Performance
NCT04852315 ·Status: COMPLETED ·Phase: NA
-
Caffeine and Resistance Training in Older Adults
NCT06618261 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Caffeine in Elderly Citizens
NCT00117520 ·Status: COMPLETED ·Phase: PHASE4
-
Caffeine, Resistance Exercise and Muscle/Cerebral Oxygenation
NCT07001176 ·Status: COMPLETED ·Phase: NA
-
Effect of Caffeine on Myocardial Oxygenation
NCT04585854 ·Status: COMPLETED ·Phase: NA
-
Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?
NCT00430170 ·Status: COMPLETED ·Phase: PHASE4
-
Caffeine and Cerebrovascular Reactivity
NCT04730193 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Hydration and Exercise Performance in Cycling
NCT03304197 ·Status: COMPLETED ·Phase: NA
-
Consequences of Caffeine Intake in Sleep Restricted Teenagers
NCT05790161 ·Status: UNKNOWN ·Phase: NA
-
The Role of Methylphenidate on Performance in the Cold
NCT04283877 ·Status: UNKNOWN ·Phase: PHASE4